Adam Acosta

Adam Acosta

Partner, White & Case LLP
[email protected]

Adam Acosta is a partner in the Washington, DC, office of White & Case LLP. Recognised by The Legal 500 in the antitrust cartel and antitrust class-action defence categories, Mr Acosta has ‘a strong reputation for successfully handling government investigations and litigating cartel/conspiracy antitrust cases, including a recent string of client wins’ in the ‘pharmaceutical sector’ (The Legal 500: US, 2021). He ‘continues to establish himself as a key player in complex cartel litigation’ and is ‘very thorough’ (The Legal 500: US, 2022).

Mr Acosta served as counsel for two pharmaceutical companies in the seminal FTC v Actavis reverse payment litigation. He has also litigated many of the major pharmaceutical antitrust matters over the past decade, including AndroGel, Asacol, Bystolic, Doryx, Effexor, Lipitor, Loestrin, Zytiga and the ongoing antitrust litigation involving HIV treatments.

Mr Acosta also routinely provides competition-related counselling to pharma clients involving competitor collaborations, settlements of patent litigation, drug pricing and distribution, trade associations, information exchanges and competitive intelligence.

Content from this author

Unlock unlimited access to all Global Competition Review content